Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Li Tu, Zhuo-Yu Wu, Xiu-Lin Yang, Qian Zhang, Ran Gu, Qian Wang, Tian Tian, Huan Yao, Xiang Qu & Jin-Yong Tian. (2019) Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA. Neuropsychiatric Disease and Treatment 15, pages 3615-3625.
Read now
Read now
Articles from other publishers (28)
Sarvenaz Sobhani, Ali-Asghar Tehrani, Golnar Sobhani, Sulail Fatima, Luis Ulloa, Majid Motaghinejad & Alina Atif. (2022) Melatonin Protects Against Titanium Oxide-Induced Neurotoxicity: Neurochemical, Neurobehavioral, and Histopathological Evidences. Biological Trace Element Research 201:8, pages 3861-3881.
Crossref
Crossref
Daniel P. Cardinali & Arturo Garay. (2023) Melatonin as a Chronobiotic/Cytoprotective Agent in REM Sleep Behavior Disorder. Brain Sciences 13:5, pages 797.
Crossref
Crossref
Sinem Gergin, Özlem Kirazlı, Hatice Boracı, Sercan Doğukan Yıldız, Hasan Raci Yananlı & Ümit Süleyman Şehirli. (2022) The effects of regular swimming exercise and melatonin on the neurons localized in the striatum of hemiparkinsonian rats. Anatomical Science International 98:2, pages 204-219.
Crossref
Crossref
Edward O. Olufunmilayo, Michelle B. Gerke-Duncan & R. M. Damian Holsinger. (2023) Oxidative Stress and Antioxidants in Neurodegenerative Disorders. Antioxidants 12:2, pages 517.
Crossref
Crossref
Jana Tchekalarova & Rumiana Tzoneva. (2023) Oxidative Stress and Aging as Risk Factors for Alzheimer’s Disease and Parkinson’s Disease: The Role of the Antioxidant Melatonin. International Journal of Molecular Sciences 24:3, pages 3022.
Crossref
Crossref
Reza Amani & Sanaz Mehrabani. 2023. Diet and Nutrition in Neurological Disorders. Diet and Nutrition in Neurological Disorders
667
697
.
Seth Mikaye Monayo & Xin Liu. (2022) The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases. Frontiers in Pharmacology 13.
Crossref
Crossref
Pablo Duarte, Patrycja Michalska, Enrique Crisman, Antonio Cuadrado & Rafael León. (2022) Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease. Antioxidants 11:2, pages 247.
Crossref
Crossref
Sendegul Yildirim, Ayse Ozkan, Gunes Aytac, Aysel Agar & Gamze Tanriover. (2022) Role of melatonin in TLR4-mediated inflammatory pathway in the MTPT-induced mouse model. NeuroToxicology 88, pages 168-177.
Crossref
Crossref
Alicia Jiménez-Delgado, Genaro Gabriel Ortiz, Daniela L. Delgado-Lara, Hector Alberto González-Usigli, Luis Javier González-Ortiz, Margarita Cid-Hernández, José Antonio Cruz-Serrano & Fermín Paul Pacheco-Moisés. (2021) Effect of Melatonin Administration on Mitochondrial Activity and Oxidative Stress Markers in Patients with Parkinson’s Disease. Oxidative Medicine and Cellular Longevity 2021, pages 1-7.
Crossref
Crossref
Özge Güzelad, Ayşe Özkan, Hande Parlak, Osman Sinen, Ebru Afşar, Eren Öğüt, Fatoş Belgin Yıldırım, Mehmet Bülbül, Aysel Ağar & Mutay Aslan. (2021) Protective mechanism of Syringic acid in an experimental model of Parkinson’s disease. Metabolic Brain Disease 36:5, pages 1003-1014.
Crossref
Crossref
Rupinder Kaur Sodhi, Yashika Bansal, Raghunath Singh, Priyanka Saroj, Ranjana Bhandari, Baldeep Kumar & Anurag Kuhad. (2021) IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson’s disease. NeuroToxicology 84, pages 184-197.
Crossref
Crossref
Santiago Pérez-Lloret & Daniel P. Cardinali. (2021) Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease. Frontiers in Pharmacology 12.
Crossref
Crossref
Andreza Fabro de Bem, Rachel Krolow, Hémelin Resende Farias, Victória Linden de Rezende, Daniel Pens Gelain, José Cláudio Fonseca Moreira, João Miguel das Neves Duarte & Jade de Oliveira. (2021) Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview. Frontiers in Neuroscience 14.
Crossref
Crossref
Jianan Lu, Yujie Luo, Shuhao Mei, Yuanjian Fang, Jianmin Zhang & Sheng Chen. (2020) The Effect of Melatonin Modulation of Non-coding RNAs on Central Nervous System Disorders: An Updated Review. Current Neuropharmacology 19:1, pages 3-23.
Crossref
Crossref
Sandro Percário, Aline da Silva Barbosa, Everton Luiz Pompeu Varela, Antônio Rafael Quadros Gomes, Michelli Erica Souza Ferreira, Thayana de Nazaré Araújo Moreira & Maria Fani Dolabela. (2020) Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation. Oxidative Medicine and Cellular Longevity 2020, pages 1-23.
Crossref
Crossref
Josiel Mileno Mack, Tainara de Menezes Moura, Franciane Bobinski, Daniel Fernandes Martins, Rodrigo A. Cunha, Roger Walz, Pedro Augusto Fernandes, Regina Pekelmann Markus, Alcir Luiz Dafre & Rui Daniel Prediger. (2020) Neuroprotective effects of melatonin against neurotoxicity induced by intranasal sodium dimethyldithiocarbamate administration in mice. NeuroToxicology 80, pages 144-154.
Crossref
Crossref
Ayse Ozkan, Hande Parlak, Aysel Agar, Özlem Özsoy, Gamze Tanriover, Sayra Dilmac, Eylem Turgut & Piraye Yargicoglu. (2020) The Effect of Sodium Metabisulphite on Apoptosis in the Experimental Model of Parkinson’s Disease. Current Nutrition & Food Science 16:3, pages 296-305.
Crossref
Crossref
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin & Jean-Noël Vallée. (2020) Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson’s Disease. Cells 9:2, pages 314.
Crossref
Crossref
Omid Reza Tamtaji, Russel J. Reiter, Reza Alipoor, Ehsan Dadgostar, Ebrahim Kouchaki & Zatollah Asemi. (2019) Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms. Cellular and Molecular Neurobiology 40:1, pages 15-23.
Crossref
Crossref
Daniel P. Cardinali. (2019) Melatonin: Clinical Perspectives in Neurodegeneration. Frontiers in Endocrinology 10.
Crossref
Crossref
Joseph Wai-Hin Leung, Way Kwok-Wai Lau, Benson W-M. Lau & Benjamin K. Yee. 2019. Psychiatry and Neuroscience Update. Psychiatry and Neuroscience Update
177
186
.
Jean A. Boutin. 2018. Melatonin - Molecular Biology, Clinical and Pharmaceutical Approaches. Melatonin - Molecular Biology, Clinical and Pharmaceutical Approaches.
Chia-Wen Tsai, Rong-Tzong Tsai, Shih-Ping Liu, Chang-Shi Chen, Min-Chen Tsai, Shao-Hsuan Chien, Huey-Shan Hung, Shinn-Zong Lin, Woei-Cherng Shyu & Ru-Huei Fu. (2018)
Neuroprotective Effects of Betulin in Pharmacological and Transgenic
Caenorhabditis elegans
Models of Parkinson’s Disease
. Cell Transplantation 26:12, pages 1903-1918.
Crossref
Crossref
ZhenXiang Zhao, JianFeng Wang, LingLing Wang, XiaoMei Yao, YiLin Liu, Ye Li, Si Chen, Tao Yue, XiaoTang Wang, WenFei Yu & YiMing Liu. (2017) Capsaicin Protects Against Oxidative Insults and Alleviates Behavioral Deficits in Rats with 6-OHDA-Induced Parkinson’s Disease via Activation of TRPV1. Neurochemical Research 42:12, pages 3431-3438.
Crossref
Crossref
Yan Li, Shu-Mei Wang, Lei Guo, Jian Zhu, Ying Wang, Lei Li & Yan-Xin Zhao. (2017) Effects of Melatonin Levels on Neurotoxicity of the Medial Prefrontal Cortex in a Rat Model of Parkinson's Disease. Chinese Medical Journal 130:22, pages 2726-2731.
Crossref
Crossref
Min Wen, Bo Zhou, Yun-Hua Chen, Zhao-Lei Ma, Yun Gou, Chun-Lin Zhang, Wen-Feng Yu & Ling Jiao. (2017) Serum uric acid levels in patients with Parkinson’s disease: A meta-analysis. PLOS ONE 12:3, pages e0173731.
Crossref
Crossref
Josiel Mileno Mack, Marissa Giovanna Schamne, Tuane Bazanella Sampaio, Renata Aparecida Nedel Pértile, Pedro Augusto Carlos Magno Fernandes, Regina P. Markus & Rui Daniel Prediger. (2016) Melatoninergic System in Parkinson’s Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms. Oxidative Medicine and Cellular Longevity 2016, pages 1-31.
Crossref
Crossref